Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “multiple sclerosis”

A Study of KHK4827 in Patients With Systemic SclerosisCompleted
NCT04368403Phase 1Updated Jul 11, 2025
Sponsor: Kyowa Kirin Co., Ltd.
Systemic Sclerosis
Japan
Unravelling The Optimisation And Consolidation Of Motor Skills In People With Multiple Sclerosis With Mild to Moderate Gait Impairment: A Feasibility StudyRecruiting
NCT07058870NAUpdated Jul 10, 2025
Sponsor: University Hospital of Ferrara
Multiple Sclerosis
Italy
Unravelling The Optimisation And Consolidation Of Motor Skills In People With Multiple Sclerosis With Severe Gait Impairment: A Feasibility StudyRecruiting
NCT07058896NAUpdated Jul 10, 2025
Sponsor: University Hospital of Ferrara
Multiple Sclerosis
Italy
Motor-cognitive Performance in People With Multiple SclerosisRecruiting
NCT06312046NAUpdated Jul 10, 2025
Sponsor: Karolinska Institutet
Multiple Sclerosis · Postural Balance
Sweden
Exploring the Profiles of RMS Patients on Ofatumumab or Ocrelizumab in a Real-World Setting in the GulfCompleted
NCT05266469N/AUpdated Jul 9, 2025
Sponsor: Novartis Pharmaceuticals
Relapsing Multiple Sclerosis
United Arab Emirates
Effect of High Intensity Training on Motor and Cognitive FunctionsRecruiting
NCT06219304NAUpdated Jul 8, 2025
Sponsor: Fondazione Don Carlo Gnocchi ETS
Multiple Sclerosis
Italy
A Study To Investigate The Pharmacokinetics, Safety, And Tolerability Of Subcutaneous Ocrelizumab Administration In Participants With Multiple SclerosisCompleted
NCT03972306Phase 1Updated Jul 8, 2025
Sponsor: Hoffmann-La Roche
Multiple Sclerosis (MS)
United States
Effects of a Circuit Training on Balance in Persons With Multiple SclerosisCompleted
NCT04006613NAUpdated Jul 8, 2025
Sponsor: Fondazione Don Carlo Gnocchi ETS
Multiple Sclerosis
Italy
hUC-MSC-sEV-001 Nasal Drops for Neurodegenerative DiseasesNot Yet Recruiting
NCT06607900Phase 1Updated Jul 8, 2025
Sponsor: Xuanwu Hospital, Beijing
Alzheimer Disease · Parkinson Disease · Lewy Body Dementia · Multiple System Atrophy
China
Impact of Direct Current Electrical Stimulation on Spasticity Levels and Functional Muscle Use in MSCompleted
NCT04942938NAUpdated Jul 4, 2025
Sponsor: CommonSpirit Health
Multiple Sclerosis
United States
The Neural Mechanisms of Split-belt Treadmill Adaptation in People With Multiple SclerosisCompleted
NCT05878873NAUpdated Jul 3, 2025
Sponsor: Colorado State University
Multiple Sclerosis
United States
ABA-101 in Participants With Progressive Multiple SclerosisActive Not Recruiting
NCT06566261Phase 1Updated Jul 3, 2025
Sponsor: Abata Therapeutics
Progressive Multiple Sclerosis
United States
Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 1)Completed
NCT04410978Phase 3Updated Jul 2, 2025
Sponsor: Sanofi
Relapsing Multiple Sclerosis
United States, Austria, Belarus, Bulgaria, Canada +19 more
Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (HERCULES)Completed
NCT04411641Phase 3Updated Jul 2, 2025
Sponsor: Sanofi
Non-relapsing Secondary Progressive Multiple Sclerosis
United States, Argentina, Australia, Austria, Belarus +26 more
Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 2)Completed
NCT04410991Phase 3Updated Jul 2, 2025
Sponsor: Sanofi
Relapsing Multiple Sclerosis
United States, Argentina, Belgium, Brazil, Canada +23 more
Telerehabilitation of Multidomain Cognitive Impairment in Multiple SclerosisTerminated
NCT05611047NAUpdated Jul 1, 2025
Sponsor: University Hospital, Bordeaux
Multiple Sclerosis
France
Simvastatin in Secondary Progressive Multiple SclerosisCompleted
NCT03896217Phase 2Updated Jul 1, 2025
Sponsor: University College, London
Secondary Progressive Multiple Sclerosis
United Kingdom
Study of SPG302 in Healthy Volunteers and ALS ParticipantsCompleted
NCT05882695Phase 1Updated Jun 29, 2025
Sponsor: Spinogenix
Amyotrophic Lateral Sclerosis
Australia
TOTEM RRMS : TestOsterone TreatmEnt on Neuroprotection and Myelin Repair in Relapsing Remitting Multiple SclerosisRecruiting
NCT03910738Phase 2Updated Jun 29, 2025
Sponsor: University Hospital, Strasbourg, France
Multiple Sclerosis, Relapsing-Remitting
France
3D OPTIMIZED WMN MPRAGE Increased Detection of Focal Spinal Cord Lesion in Multiple Sclerosis (WHINUME)Recruiting
NCT05227092NAUpdated Jun 29, 2025
Sponsor: University Hospital, Bordeaux
Multiple Sclerosis
France
Ocrelizumab VErsus Rituximab Off-Label at the Onset of Relapsing MS DiseaseActive Not Recruiting
NCT04578639Phase 3Updated Jun 27, 2025
Sponsor: Haukeland University Hospital
Relapsing Remitting Multiple Sclerosis
Norway, Sweden
A Post-Authorization, Long-term Study of Ozanimod Real-world SafetyActive Not Recruiting
NCT05605782N/AUpdated Jun 26, 2025
Sponsor: Bristol-Myers Squibb
Multiple Sclerosis, Relapsing-Remitting
United States
Exergaming With Immersive Virtual Reality For People With Multiple Sclerosis (ExeRVIEM)Completed
NCT05870254NAUpdated Jun 26, 2025
Sponsor: University of Vigo
Multiple Sclerosis · Physical Therapy · Exercise · Virtual Reality Exposure Therapy
Spain
Exopulse Mollii Suit, Spasticity & Tissue OxygenationCompleted
NCT05362006NAUpdated Jun 26, 2025
Sponsor: Institut De La Colonne Vertebrale Et Des Neurosciences
Multiple Sclerosis
France
Effectiveness of the Combination Strategy of Disease-Modifying Therapy and the Yishen Daluo Yin Modified Formula for Multiple SclerosisNot Yet Recruiting
NCT07037823N/AUpdated Jun 26, 2025
Sponsor: Ying Gao
RRMS

Previous page Next page